Literature DB >> 16925948

Ubiquitin and ubiquitin-like modifications of the p53 family.

Ian R Watson1, Meredith S Irwin.   

Abstract

Regulation of p53 by the ubiquitin-proteasomal pathway has been studied considerably. Studies have also demonstrated that the ubiquitin-like proteins SUMO-1 and NEDD8 modify p53. Similarly, p63 and p73 are subject to regulation by ubiquitin and ubiquitin-like modifications, and perturbations of these pathways in the regulation of the p53 family have been implicated in tumorigenesis and developmental abnormalities. Here, we provide an overview of the current understanding of the regulation of the p53 family by covalent modification by ubiquitin, SUMO-1, and NEDD8.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16925948      PMCID: PMC1601941          DOI: 10.1593/neo.06439

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  139 in total

Review 1.  Ubiquitin-like proteins: new wines in new bottles.

Authors:  E T Yeh; L Gong; T Kamitani
Journal:  Gene       Date:  2000-05-02       Impact factor: 3.688

2.  Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.

Authors:  J Gu; D Chen; J Rosenblum; R M Rubin; Z M Yuan
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 3.  RING finger proteins: mediators of ubiquitin ligase activity.

Authors:  C A Joazeiro; A M Weissman
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

4.  Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).

Authors:  M Morimoto; T Nishida; R Honda; H Yasuda
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

5.  Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.

Authors:  M A Read; J E Brownell; T B Gladysheva; M Hottelet; L A Parent; M B Coggins; J W Pierce; V N Podust; R S Luo; V Chau; V J Palombella
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

7.  c-Jun and p53 activity is modulated by SUMO-1 modification.

Authors:  S Muller; M Berger; F Lehembre; J S Seeler; Y Haupt; A Dejean
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

8.  An anti-apoptotic role for the p53 family member, p73, during developmental neuron death.

Authors:  C D Pozniak; S Radinovic; A Yang; F McKeon; D R Kaplan; F D Miller
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

9.  Regulation of p53 activity in nuclear bodies by a specific PML isoform.

Authors:  V Fogal; M Gostissa; P Sandy; P Zacchi; T Sternsdorf; K Jensen; P P Pandolfi; H Will; C Schneider; G Del Sal
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

10.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

View more
  25 in total

Review 1.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

2.  Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation.

Authors:  Avigail D Amsel; Moran Rathaus; Noam Kronman; Haim Y Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

3.  Isopeptidases in anticancer therapy: looking for inhibitors.

Authors:  Andrea Sgorbissa; Harish Potu; Claudio Brancolini
Journal:  Am J Transl Res       Date:  2010-05-10       Impact factor: 4.060

4.  A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.

Authors:  Benjamin Ory; Matthew R Ramsey; Catherine Wilson; Douangsone D Vadysirisack; Nicole Forster; James W Rocco; S Michael Rothenberg; Leif W Ellisen
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

5.  Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.

Authors:  Ezgi Karaca; Melda Tozluoğlu; Ruth Nussinov; Türkan Haliloğlu
Journal:  J Mol Biol       Date:  2011-01-07       Impact factor: 5.469

6.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

7.  Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice.

Authors:  Xiaoyan Yin; Xiuli Cong; Ming Yan; Dong-Er Zhang
Journal:  Lung Cancer       Date:  2008-06-24       Impact factor: 5.705

8.  1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.

Authors:  Yingyu Ma; Wei-Dong Yu; Pamela A Hershberger; Geraldine Flynn; Rui-Xian Kong; Donald L Trump; Candace S Johnson
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

9.  Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions.

Authors:  Federico Mauri; Laura M McNamee; Andrea Lunardi; Fulvio Chiacchiera; Giannino Del Sal; Michael H Brodsky; Licio Collavin
Journal:  J Biol Chem       Date:  2008-05-20       Impact factor: 5.157

10.  Plk1-mediated phosphorylation of Topors regulates p53 stability.

Authors:  Xiaoming Yang; Hongchang Li; Zinan Zhou; Wen-Horng Wang; Anping Deng; Ourania Andrisani; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.